Download PDF

1. Company Snapshot

1.a. Company Description

Nu Skin Enterprises, Inc.develops and distributes beauty and wellness products worldwide.It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products.


The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, LifePak nutritional supplements, ageLOC Meta nutritional supplements, and Beauty Focus Collagen+ skin care supplements, as well as other weight management products.In addition, it is involved in the research and product development of skin care products and nutritional supplements.Further, the company operates retail stores and service centers in Mainland China.


It sells its products under the Nu Skin, Pharmanex, and ageLOC brands.The company promotes and sells its products directly, as well as through distributors and Website.Nu Skin Enterprises, Inc.


was founded in 1984 and is headquartered in Provo, Utah.

Show Full description

1.b. Last Insights on NUS

Negative drivers behind Nu Skin Enterprises' recent 3-month performance include a tough operating backdrop and pressures within the direct selling industry. The company's Q4 2024 results reflect lower revenues and higher earnings, with an adjusted operating margin expanding 130 bps year-over-year. Additionally, the company's customer base declined by 15% year-over-year, and paid affiliation numbers also decreased. Furthermore, the company's Rhyz revenue growth of 27.7% was not enough to offset the decline in overall revenue.

1.c. Company Highlights

2. Nu Skin's Q3 2025 Earnings: A Step Towards Intelligent Wellness

Nu Skin Enterprises reported Q3 2025 revenue of $364.2 million, with a 40 basis point headwind from foreign currency, and earnings per share (EPS) of $0.34, beating estimates of $0.3. The company's gross margin for the quarter was 70.5%, up from 70.1% in the prior year, driven by strategic product positioning and cost efficiency initiatives. As James Thomas, CFO, noted, the company has seen consistent gross margin improvement over five quarters. The revenue came in within guidance, and EPS was at the higher end of guidance.

Publication Date: Nov -24

📋 Highlights
  • Q3 2025 Revenue & EPS Performance: Revenue hit $364 million (within guidance) and EPS reached $0.34 (at the high end of guidance).
  • Latin America Growth: Achieved 53% Y/Y revenue growth, contrasting with North America's challenges and Southeast Asia's $84 billion intelligent wellness market potential.
  • Prysm iO Launch & India Expansion: Plans to deploy 10,000+ Prysm iO units in Q4 2025 and scale to tens of thousands quarterly in 2026, while entering India with a localized portfolio and digital-first model.
  • Gross Margin Improvement: Gross margin rose to 70.5% (up 40 bps Y/Y), driven by cost efficiencies and strategic product positioning.

Regional Performance

Latin America saw significant year-over-year growth of 53%, while North America faced challenges. Southeast Asia saw strong sequential growth, driven by markets like Australia, New Zealand, and Singapore. The company is refining its business model in North America, shifting focus from beauty to intelligent wellness, a market expected to reach $84 billion. Nu Skin's Prysm iO device and AI-powered app are well-positioned in this market, and the company expects this to drive growth in North America.

Strategic Priorities

The company's top priorities are igniting passion among sales leaders and expanding into emerging markets, particularly India. Nu Skin is entering India with a localized product portfolio, refined compensation plan, and digital-first infrastructure. The company expects India to become a significant part of its core business revenue in the coming years. The introduction of Prysm iO, a truly intelligent wellness platform, is also a key strategic priority. The company expects to place over 10,000 Prysm iO units in Q4 and tens of thousands per quarter in 2026.

Valuation and Outlook

Nu Skin's current valuation metrics indicate a relatively stable position, with a P/E Ratio of 4.52, P/B Ratio of 0.62, and P/S Ratio of 0.32. The company's ROE is 14.65%, indicating a decent return on equity. Analysts estimate next year's revenue growth at 2.1%. With the introduction of Prysm iO and expansion into India, Nu Skin is well-positioned for growth and improved profitability. The company's focus on aligning its teams, building support, and driving excitement is expected to achieve its vision of becoming the world's leading intelligent beauty, wellness, and lifestyle leadership opportunity platform.

3. NewsRoom

Card image cap

3 Beauty & Cosmetic Stocks Set to Ride on the Next Wave of Growth

Nov -25

Source: zacks.com

Card image cap

Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 2025 Q3

Nov -07

Source: newsfilecorp.com

Card image cap

Nu Skin Enterprises, Inc. (NUS) Q3 2025 Earnings Call Transcript

Nov -07

Source: seekingalpha.com

Card image cap

Nu Skin Enterprises Reports Third Quarter Earnings

Nov -06

Source: businesswire.com

Card image cap

Nu Skin Enterprises Announces Quarterly Dividend

Nov -06

Source: businesswire.com

Card image cap

Nu Skin to Report Q3 Earnings: What's in the Cards for NUS Stock?

Nov -05

Source: zacks.com

Card image cap

Ethic Inc. Reduces Stake in Nu Skin Enterprises, Inc. $NUS

Oct -31

Source: defenseworld.net

Card image cap

Reviewing Nu Skin Enterprises (NYSE:NUS) and Solesence (NASDAQ:SLSN)

Oct -21

Source: defenseworld.net

4. Business Breakdown

4.a. Revenues by Country

4.b. Revenues by Segment

5. Expected revenues mid-term growth (8.10%)

6. Segments

Pharmanex

Expected Growth: 8.4%

Pharmanex's 8.4% growth driven by increasing demand for anti-aging and wellness products, expansion into new markets, and strong online sales. Additionally, Nu Skin's investment in digital marketing and e-commerce platform enhancements have improved customer engagement and retention. The company's focus on product innovation, particularly in the ageLOC brand, has also contributed to growth.

Nu Skin

Expected Growth: 7.8%

Nu Skin's 7.8% growth is driven by increasing demand for anti-aging products, expansion into emerging markets, and a strong online presence. The company's focus on innovation, particularly in the areas of skin care and wellness, has also contributed to its growth. Additionally, Nu Skin's business model, which combines direct sales with e-commerce, has enabled the company to reach a wider customer base and capitalize on the trend towards online shopping.

Other

Expected Growth: 8.1%

Nu Skin's 'Other' segment, with 8.1% growth, is driven by increasing demand for its manufacturing and product development services, as well as its investment in digital platforms, enabling seamless customer experiences and expanding its global reach.

7. Detailed Products

AgeLOC

A line of anti-aging products that target the sources of aging to promote healthy, youthful-looking skin

Nutricentials

A line of nutritional supplements that support overall health and wellness

TR90

A weight management system that helps individuals achieve and maintain a healthy weight

Pharmanex

A line of nutritional supplements that support healthy aging and overall wellness

Epoch

A line of natural, botanical-based personal care products

8. Nu Skin Enterprises, Inc.'s Porter Forces

Forces Ranking

Threat Of Substitutes

The threat of substitutes for Nu Skin Enterprises, Inc. is medium due to the presence of alternative products in the market, but the company's strong brand recognition and customer loyalty mitigate this threat.

Bargaining Power Of Customers

The bargaining power of customers for Nu Skin Enterprises, Inc. is low due to the company's strong brand recognition and customer loyalty, which reduces the ability of customers to negotiate prices.

Bargaining Power Of Suppliers

The bargaining power of suppliers for Nu Skin Enterprises, Inc. is medium due to the company's dependence on a few key suppliers, but the company's strong relationships with suppliers mitigate this threat.

Threat Of New Entrants

The threat of new entrants for Nu Skin Enterprises, Inc. is high due to the low barriers to entry in the industry, but the company's strong brand recognition and customer loyalty provide a competitive advantage.

Intensity Of Rivalry

The intensity of rivalry for Nu Skin Enterprises, Inc. is high due to the presence of several competitors in the market, but the company's strong brand recognition and customer loyalty provide a competitive advantage.

9. SWOT Analysis

Strength

Weaknesses

Opportunities

Threats

10. Capital Structure

10.a. Balance Sheet

10.b. Weighted Average Cost of capital

Value
Debt Weight 39.06%
Debt Cost 3.95%
Equity Weight 60.94%
Equity Cost 9.56%
WACC 7.37%
Leverage 64.11%

11. Quality Control: Nu Skin Enterprises, Inc. passed 3 out of 9 key points

12.a Historical Valuation

12.b Price/Earnings Ratio

12.c Margin Valuation

12.d Peers Valuation

Peers Group Analysis

Stock-Card
Nu Skin

A-Score: 5.9/10

Value: 8.5

Growth: 2.2

Quality: 6.4

Yield: 5.0

Momentum: 10.0

Volatility: 3.0

1-Year Total Return ->

View Full Report
Stock-Card
Acme United

A-Score: 4.8/10

Value: 3.8

Growth: 4.8

Quality: 6.3

Yield: 4.0

Momentum: 4.0

Volatility: 5.7

1-Year Total Return ->

View Full Report
Stock-Card
Mannatech

A-Score: 4.7/10

Value: 8.6

Growth: 2.1

Quality: 4.4

Yield: 4.0

Momentum: 8.0

Volatility: 1.3

1-Year Total Return ->

View Full Report
Stock-Card
Edgewell

A-Score: 4.3/10

Value: 6.6

Growth: 3.9

Quality: 3.8

Yield: 5.0

Momentum: 0.5

Volatility: 6.0

1-Year Total Return ->

View Full Report
Stock-Card
Grove Collaborative

A-Score: 4.3/10

Value: 8.2

Growth: 4.7

Quality: 4.0

Yield: 0.0

Momentum: 7.0

Volatility: 1.7

1-Year Total Return ->

View Full Report
Stock-Card
European Wax Center

A-Score: 4.0/10

Value: 6.8

Growth: 5.2

Quality: 5.3

Yield: 3.0

Momentum: 1.5

Volatility: 2.3

1-Year Total Return ->

View Full Report

Peers Metrics

12.e Scoring Insights

12.f DCF BETA

Parameters

Short Term Growth

Short term Time

Long-Term Growth

WACC

Target Price

9.98$

Current Price

9.98$

Potential

-0.00%

Expected Cash-Flows